Skip to main content

Table 1 Relevant medical information requested by the pharmacists

From: Provision of pharmaceutical care to suspected high-risk COVID-19 patients through telehealth: a nationwide simulated patient study

A. Patient’s information and medical history regarding DM

n (or %)*

Age

12

Pregnancy/lactation

0

Duration of DM

0

FBG and RBG readings

33

Frequency of routine DM clinic visits

0

Other chronic medical condition(s)

0

Chronic medication(s)

22

Adherence to diet and physical activity

20

Controlled/uncontrolled DM before the onset of new symptoms

17

Presence of fruity-smelling breath

0

Constant/fluctuating insulin doses before the onset of new symptoms

0

None of the above was obtained by the pharmacist

61

B. Assessment of COVID-19 exposure

 

Occupation (to rule out high-risk occupations such as HCP and LTCF personnel)

4

Residence and members sharing living

6

Close contact with someone with symptoms, or diagnosed or tested positive for COVID-19 within 2 weeks before feeling sick

29

Travel history

0

Attending a social gathering, or being in crowded indoor settings

7

None of the above was obtained by the pharmacist

70

C. Assessment of COVID-19-related symptoms and treatments

 

Symptoms of COVID-19 (e.g., cough, shortness of breath or difficulty breathing, fever or chills, muscle or body aches, recent loss of taste or smell, vomiting or diarrhea)

57

Onset and duration of symptoms

21

Life-threatening symptoms

7

Medications used to manage symptoms

10

History of flu vaccination

3

None of the above was obtained by the pharmacist

41

  1. DM diabetes mellitus, FBG fasting blood glucose, HCP health care provider, LTCF long-term care facility, RBG random blood glucose
  2. *Since the number of pharmacists is 100, the result indicates the percentage too. As mixed responses were given, numbers do add up to 100